cilengitide has been researched along with relacatib in 1 studies
| Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (relacatib) | Trials (relacatib) | Recent Studies (post-2010) (relacatib) |
|---|---|---|---|---|---|
| 194 | 29 | 133 | 8 | 0 | 0 |
| Protein | Taxonomy | cilengitide (IC50) | relacatib (IC50) |
|---|---|---|---|
| Procathepsin L | Homo sapiens (human) | 0.002 | |
| Cathepsin B | Homo sapiens (human) | 0.014 | |
| Cathepsin S | Homo sapiens (human) | 0.008 | |
| Cathepsin K | Homo sapiens (human) | 0.0005 | |
| Cathepsin K | Oryctolagus cuniculus (rabbit) | 0.0005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, JG; Babij, P; Fotsch, C | 1 |
1 review(s) available for cilengitide and relacatib
| Article | Year |
|---|---|
Emerging targets in osteoporosis disease modification.
Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis | 2010 |